What is Candel Therapeutics, Inc.'s price / sales?

Candel Therapeutics, Inc. (CADL) reported price / sales of 417.2× in Q4 2022.

How has Candel Therapeutics, Inc.'s price / sales changed year-over-year?

Candel Therapeutics, Inc.'s price / sales decreased by 76.9% year-over-year, from 1,809.4× to 417.2×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Candel Therapeutics, Inc. CADL Price / sales

Discontinued — last reported Q4 '22

Price / sales at other companies

Bristol-Myers SquibbBMY

2.6×-0.1×

AmgenAMGN

5.1×+0.2×

Gilead SciencesGILD

5.8×+1.0×

CG OncologyCGON

1,126.9×-1,693×

CytomX TherapeuticsCTMX

28.6×+28.2×

RegenxbioRGNX

4.9×+2.6×

Other financials

Income statement

See full

Revenue$31.0K0.0%

Operating income-$16.3M-100%

Net income-$8.9M-220%

EPS (diluted)-$0.14-208%

Balance sheet

See full

Cash & equivalents$194.8M+111%

Total debt$2.8M-73.9%

Total equity$138.0M+84.8%

Total assets$201.9M+111%

Cash flow

See full

Operating cash flow-$18.0M-109%

CapEx$675.0K+22,400%

Free cash flow-$18.7M-117%

Valuation

See full

Market cap$693.87M+192%

Enterprise value$501.88M+220%

Profitability

See full

Operating margin-28,000.8%+15,050pp

Net margin-15,156.5%-5,064pp

FCF margin-26,383.9%+14,851pp

Returns & leverage

See full

Return on equity-51.2%-16.6pp

Debt / equity0×-0.1×

Current ratio28×+23.4×

Where this comes from

Calculated from Candel Therapeutics, Inc.’s reported figures.

market cap/total revenue=417.2×

Based on the most recent quarter.

The official record: Candel Therapeutics, Inc.’s 10-K, filed March 28, 2024, on SEC EDGAR. View the filing →

Ask your AI about Candel Therapeutics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Candel Therapeutics, Inc.'s price / sales?: Candel Therapeutics, Inc. (CADL) reported price / sales of 417.2× in Q4 2022.
How has Candel Therapeutics, Inc.'s price / sales changed year-over-year?: Candel Therapeutics, Inc.'s price / sales decreased by 76.9% year-over-year, from 1,809.4× to 417.2×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.